you're probably going to rely on car commercials. Like all TV commercials, car commercials are short ads designed to hype up a product and convince you to buy it, or at the very least look into it.

Commercial Vehicle (CV) industry is expected to witness a growth of 3-5 percent in FY26, according to an ICRA report. The growth will be driven by infrastructure projects, rural demand ...

Investing.com - Uncertainty around U.S. President Donald Trump's trade policies has partly led analysts at Citi to slash their full-year estimates for the commercial vehicle sector. In a note to ...

Tata Motors' increase—up to 2% across its commercial vehicle range—will vary by model and variant. Tata Motors, India's largest commercial vehicle manufacturer, will implement a price increase ...

Revenue: US$723.4m (down 27% from FY 2023). Net loss: US$35.7m (down by 172% from US$49.4m profit in FY 2023). US$1.07 loss per share (down from US$1.50 profit in FY 2023). Revenue missed analyst ...

Another achievement for MLMML is surpassing the sale of 200,000 commercial EVs, a first in the industry. Notably, the Treo, ...

van or other vehicle you use for work That's when you need commercial auto insurance. It provides the same protections as your personal policy, including liability, collision and medical expenses ...

Drivers using personal auto insurance policies for business vehicle use could face penalties or denied coverage claims. Driving for business without commercial auto insurance is a bad move.

And it had already built some of the most powerful rockets developed by the Chinese commercial sector. Our first conversation took place after his company’s Gravity-1 medium-lift launch vehicle ...

Mahindra Last Mile Mobility (MLMML) leads India's commercial EV market with a 37.3% share, driven by the Treo, Zor Grand, and ...

With a 25% tariff about to hit every imported car, many Americans are wondering whether it’s better to buy or lease a vehicle before tariffs go into effect, or wait to see how things will play out.

Nevertheless, the cost-cutting approach in integrating the unit may reflect larger concerns about the commercial potential of CAR-T therapies. Dr Clive Stanway, Cancer Research Technology's chief ...